LESSON 5.2 WORKBOOK. What do cancer screens really tell us? Workbook Lesson 5.2
|
|
- Aubrey White
- 5 years ago
- Views:
Transcription
1 Mortality rate The rate at which people die from a specific cancer. For a complete list of defined terms, see the Glossary. LESSON 5.2 WORKBOOK What do cancer screens really tell us? Treating cancer successfully requires that we are able to detect it early. As more diagnostic techniques are developed it becomes important to understand how reliable they are how many cancers will they miss and how many times will they indicate that cancer is present when it is not? This lesson discusses the concepts of sensitivity and specificity and shows how screens can lead to overdiagnosis and why overdiagnosis poses a problem, using recent findings with breast and prostate cancers as an example. Evaluating cancer screens: specificity and sensitivity As we have discussed in previous lessons, an abiding problem with cancer treatment is that symptoms may appear well after the primary cancer has metastasize When this happens it is almost inevitable that the cancer has become more difficult, even too difficult to treat. It is clear that reliable screens to help us identify those benign tumors that are going to become malignant and malignant tumors before they metastasize are key. In the last lesson we began to examine the screening programs that are available to identify tumors at these early stages. But in order to evaluate how useful a screening program may be we need to have more information than how it works. We need to know whether it is effective in detecting tumors at the important stages before metastasis and whether it targets tumors for treatment that would never have been problemati These kinds of evaluation pose another problem the difference between population statistics and individual behavior. When a program is evaluated on the basis of its effectiveness for the population as a whole it gives no information to an individual as to how they themselves might fare. Sometimes an individual may fare in the same way as most of the population. Other times they may act like outliers and have an experience very different from the population as a whole. This is another challenge that we need to deal with when assessing which screens and treatments are most effective. Notes: 153
2 Specificity how accurate a screen is in identifying abnormal cells. False negatives Those cells (or people) that are abnormal, but are falsely identified as being normal. Sensitivity how likely a screen is identify abnormal cells. False positives Those cells (or people) that are normal, but are falsely identified as being abnormal. Let s assume we are evaluating two screens that have been designed, like the Pap smear, to detect pre-cancerous and malignant cells. Let s say one screen detects the abnormal cells by dying a protein in the cells red, while the second screen detects abnormal cells by their shape. We evaluate the screens using two criteri The specificity of a screen tells us how accurate the screen Figure 1: Two sample screens for a population. A highly specific screen (Screen 1) will only identify diseased individuals, but may miss people who are diseased that do not test positive for the screen. A highly sensitive screen (Screen 2) will identify everyone with the disease, but may falsely identify some people as having disease that actually don t. is in identifying abnormal cells. The red screen would be good at identifying cells that are red, but will miss cells that are abnormal - if they aren t strongly red for example. These cells will be called false negatives ; that is, they are abnormal, but the screen hasn t detected them. On the other hand the sensitivity of a screen tells us how likely the screen is to identify abnormal cells. A cell shape screen will identify cells that are clearly abnormal well, but it may be more likely to define cells as abnormal that are really normal. These cells will be called false positives. Figure 1 compares how two different screens on a population of people some of whom are normal (green smiley faces) and some of whom are sick (orange sad faces). Screen 1 is in purple. Out of the 10 people in the population it has correctly identified 20% as sick and correctly identified all the normal people. However it has missed 20% of the population. These false negatives are sick but think they re normal. Screen 2 is in re Out of the 10 people in the population it has detected everyone who is sick, but it has also identified 30% of the normal population as sick These false positives are really normal. In reality all screens struggle to achieve the right balance between false negatives and positives but what is right? 1. According to Figure 1, how many people are false positives detected by Screen 2? 20%. 30%. 70%. 80%. 2. True or False: The best screens will have no false positives and no false negatives 154
3 Non-progressing cancers cancers that have evolved such that they can no longer grow or spread to other tissues. These cancers will not cause disease. Overdiagnosis of cancer diagnosis of cancer that will never be life-threatening. Screening outcomes: the problem of overdiagnosis Figure 2: Model for progression of abnormal (cancer) cells. Fast growing tumors will be likely to cause disease and death from cancers, while patients with slow growing tumors and non-progressing tumors will likely die from unrelated causes before they will die from cancer. One important take-home message from this module is that cancer is the end-point of an evolutionary process that starts with a normal cell becoming able to hyperproliferate and ends with metastases. But there is no single path from benign to malignant and metastati Figure 1 illustrates four distinct ways the disease could progress from an initial screen (indicated by the abnormal cell in the bottom left. In the 1st model very fast the cancers progresses very quickly. Individuals will likely display symptoms very quickly after the cancer has been detected and are likely to die if they are not treate Clearly they would suffer greatly if they were a false negative on the screen, as would individuals in the 2nd model fast. On the other hand, in the 3rd model slow and the 4th model nonprogressing the cancer is growing so slowly that they will more likely to die from unrelated causes (like age) than they will from the cancer itself. This group would not suffer physically at all if their cancer was never identifie Not only that they will also be spared considerable non-productive anxiety over the years. The $64,000 question an informed patient would want answered is: Before I get tested how can you tell which model my cancer would fall under if it was detected?. It should be very clear from this module that we are still nowhere near having an answer to that critical question. Because of this the strategy that has been used is to screen and treat all cancers as though they fall into the worst case scenario that is if a screen detects evidence of a benign tumor, treat it as if it will become malignant, if it detects evidence of a malignant tumor treat it as if it will metastasize. This strategy would be appropriate for Models 1 and 2, but not for Models 3 and 4. The problem it causes has been termed overdiagnosis. Overdiagnosis then results in overtreatment. We can easily understand why overtreatment is problematic simply by knowing that the three major cancer treatments we have available, namely surgery, radiation, and chemotherapy are commonly referred to as slash, burn, and poison. Because cancer treatments themselves are so painful and traumatic, the decisions to treat when it is not required should not be taken lightly.. 3. True or False: All cancers will progress to metastasis. 155
4 US Preventative Services Task Force (USPSTF) a governmental agency responsible for determining guidelines for screening programs for the population. Prostate-specific antigen a protein that is produced by prostate cancer cells that is secreted into the bloo This protein has been used as a diagnostic test for prostate cancer. Cancer overdiagnosis and overtreatment Breast Cancer Mammograms have been used as routine screens for detection of breast tumors since the 1980s. Programs to raise awareness of breast cancer have promoted the notion that early detection is the key to a cure for breast cancer. And the best method for early detection was a yearly mammogram for every woman over the age of 40. Recently, the US Preventative Services Task Force (USPSTF), a governmental agency charged with determining the guidelines for screening programs throughout the country, changed these recommendations. Now mammograms are only recommended for women over the age of 50 and then only every 1-2 years, not necessarily annually. Figure 3: Since mammograms were introduced as routine screens in the 70s, there has been a rise in detected cancer, but this rise has not increased in a rise of late stage cancers. We are identifying many more cancers, but these may never become problemati These changes left many people perplexe What had happened? Was early detection no longer the key to cure? In fact the USPSTF report provided good evidence that the original mammogram screening program had detected many more early stage breast tumors and cancers (which is why the blue line in Figure 1 rises). However this increased detection hadn t improved the rate at which late stage cancers were diagnosed (the brown line in Figure 1 stays flat). Why not? The problem comes in connecting detection with cure. The USPSTF realized that most of the early stage tumors the mammogram screening program was detecting would never become the late stage aggressive metastatic cancers that cause severe disease (if they did the brown line in Figure 1 would fall). So, the screens were actually overdiagnosing cancer, by identifying women under age 50 who had malignant tumors in the Model 3 and Model 4 category. Many of those women were often also overtreated with extensive surgeries leading to extreme anxiety. 4. Overdiagnosis is a problem because: (Circle all correct.) Screens will falsely identify people with cancer who don t have disease. People don t need to know if they have cancer. Cancer treatment is so painful and traumati Some cancers will not ever metastasize and cause severe symptoms. 5. Why did the USPSTF change recommendations for mammograms? (Circle all correct.) They were trying to reduce overdiagnosis of breast cancer. Mammograms are unaffordable under most health care plans. The identification of late stage cancer was not being reduced by mammogram screenings. Early stage cancers were not being identified early enough. 6. True or False: Screening recommendations for the population are always under review. 156
5 Double mastectomy surgical removal of both breasts. Prostate Cancer Prostate cancer is extremely common it has been estimated that 80% of men over the age of 80 have a prostate cancer diagnosis. The early detection, early cure principle pushed for development of a routine screen. The prostate gland supplies the fluid for semen, and produces a protein called prostate-specific antigen (PSA), which promotes sperm movement. The prostate normally secretes low levels of PSA into the bloo Whenever the prostate is damaged, the secreted PSA levels in the blood rise. This is particularly true when prostate cells are hyperproliferating. Because of this, men over the age of 50 were recommended to have regular screens for blood PSA levels. If levels were high they were recommended for either surgery or radiation. Both of these treatment options are highly unpleasant. Because of the location of the prostate close to the urinary tract and genitals surgery commonly left men incontinent or impotent or both. Recently these recommendations have also changed and the USPSTF now no longer recommends PSA screens at all. Why? Two main reasons: First, prostate glands increase secretion of PSA whenever they are damaged, not just during cancer and many men, particularly aging men have high levels of PSA for other reasons such as because the prostate is inflame Second even though prostate cancer might be present and correlated with high PSA levels, this does not necessarily mean that a cancer will progress. In fact most prostate cancers fall solidly in Model 4 they never progress to severe disease. The recommended approach now is watchful waiting. The physician will regularly monitor a prostate tumor and only perform surgery or radiation treatment when there is evidence it is growing. Genetic Screens Cancer research has pinpointed mutations in several genes that are hallmarks for cancer. Individuals having these mutations may be predisposed to developing cancer since their cells are already on the way to becoming able to hyperproliferate. In particular certain combinations of mutations have clearly been associated with increased incidence (mutations to both BRCA 1 and 2 for example predispose to both breast and ovarian cancer). Angelina Jolie inherited both BRCA mutations and chose to have prophylactic surgery - she underwent a double mastectomy thereby reducing her risk of developing breast cancer by over 90%. However single mutations may never progress to cancer formation, and hence prophylactic surgery in this case is likely to be overtreatment. As we ve described in this module, it takes many steps for a tumor to become a cancer, and we are not able to predict what path any once cell will take. While some people might favor life-altering cancer treatment under any conditions, others might alter their treatment plan if they understand when receiving a diagnosis of cancer does not necessarily meant developing a life-threatening disease. Individual health choices may vary from what the USPSTF recommends, but it is important that these choices are made through informed decisions. 7. Which of the following is a reason that PSA screens are not recommended for prostate cancer? (Circle all correct.) The PSA test is not very accurate in identifying PSA levels. Prostate cancer is a slowgrowing disease. Many people have high blood PSA levels normally. PSA is secreted non-specifically. 8. True or false: A genetic screen of your DNA sequence will reduce your risk of cancer overdiagnosis. 157
6 STUDENT RESPONSES Explain how specificity and sensitivity are a trade-off in cancer screens. Also, what instances would you want a highly specific cancer screen? When would you want a highly sensitive cancer screen? (Hint think about severity of disease vs. severity of treatment.) Remember to identify your sources 158
7 TERMS For a complete list of defined terms, see the Glossary. TERM Double mastectomy False negatives False positive Non-progressing cancers Overdiagnosis of cancer Prostate-specific antigen Sensitivity Specificity US Preventative Services Task Force (USPSTF) DEFINITION Surgical removal of both breasts. Those cells (or people) that are abnormal, but are falsely identified as being normal. Those cells (or people) that are normal, but are falsely identified as being abnormal. Cancers that have evolved such that they can no longer grow or spread to other tissues. These cancers will not cause disease. Diagnosis of cancer that will never be life-threatening. A protein that is produced by prostate cancer cells that is secreted into the bloo This protein has been used as a diagnostic test for prostate cancer. How likely a screen is identify abnormal cells. How accurate a screen is in identifying abnormal cells (or people). A governmental agency responsible for determining guidelines for screening programs for the population. 159
Let s look a minute at the evidence supporting current cancer screening recommendations.
I m Dr. Therese Bevers, Medical Director of the Cancer Prevention Center and Professor of Clinical Cancer Prevention at The University of Texas MD Anderson Cancer Center. Today s lecture is on screening
More informationScreening for Breast Cancer
Understanding Task Force Recommendations Screening for Breast Cancer U.S. Preventive Services Task Force (Task Force) has issued a final recommendation statement on Screening for Breast Cancer. se final
More informationOverview. What is Cancer? Prostate Cancer 3/2/2014. Davis A Romney, MD Ironwood Cancer and Research Centers Feb 18, 2014
Prostate Cancer Davis A Romney, MD Ironwood Cancer and Research Centers Feb 18, 2014 Overview Start with the basics: Definition of cancer Most common cancers in men Prostate, lung, and colon cancers Cancer
More informationProstate Cancer. Biomedical Engineering for Global Health. Lecture Fourteen. Early Detection. Prostate Cancer: Statistics
Biomedical Engineering for Global Health Lecture Fourteen Prostate Cancer Early Detection Prostate Cancer: Statistics Prostate gland contributes enzymes, nutrients and other secretions to semen. United
More informationShared Decision Making in Breast and Prostate Cancer Screening. An Update and a Patient-Centered Approach. Sharon K. Hull, MD, MPH July, 2017
Shared Decision Making in Breast and Prostate Cancer Screening An Update and a Patient-Centered Approach Sharon K. Hull, MD, MPH July, 2017 Overview Epidemiology of Breast and Prostate Cancer Controversies
More informationQuestions and Answers About the Prostate-Specific Antigen (PSA) Test
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Questions and Answers
More informationBRCA genes and inherited breast and ovarian cancer. Information for patients
BRCA genes and inherited breast and ovarian cancer Information for patients This booklet has been written for people who have a personal or family history of breast and/or ovarian cancer that could be
More informationShould I Get a Mammogram?
Should I Get a Mammogram? Ages 75+ BREAST CANCER SCREENING This photo is for illustrative purposes only, and the person depicted in the photograph is a model. An affiliation between Central Washington
More informationAFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options
AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options INTRODUCTION This booklet describes how prostate cancer develops, how it affects the body and the current treatment methods. Although
More informationLESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2
For a complete list of defined terms, see the Glossary. Transformation the process by which a cell acquires characteristics of a tumor cell. LESSON 3.2 WORKBOOK How do normal cells become cancer cells?
More informationReading for Evidence: Cancer Understandings
Cancer Education Project Reading for Evidence: Cancer Understandings Overview: This activity provides background information about the statements in the Truth/Myth Survey, and asks students to select evidence
More informationProstate Cancer Screening. A Decision Guide
Prostate Cancer Screening A Decision Guide This booklet was developed by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). Is screening right for you?
More informationProstate Cancer Screening (PDQ )
1 di 7 03/04/2017 12.22 NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute
More informationScreening for Prostate Cancer US Preventive Services Task Force Recommendation Statement
Clinical Review & Education JAMA US Preventive Services Task Force RECOMMENDATION STATEMENT Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement US Preventive Services
More information4.5% 4.0% 3.5% 3.0% 2.5% 2.0% 1.5% 1.0% 0.5% 0.0% < >80 Current Age (Yrs)
Biomedical Engineering for Global Health Lecture Twelve Prostate Cancer Early Detection Prostate Cancer: Statistics Prostate gland contributes enzymes, nutrients and other secretions to semen. United States:
More informationHow often should I get a mammogram?
How often should I get a mammogram? Ages 50-74 BREAST CANCER SCREENING This photo is for illustrative purposes only, and the person depicted in the photograph is a model. An affiliation between Central
More informationProstate-Specific Antigen (PSA) Test
Prostate-Specific Antigen (PSA) Test What is the PSA test? Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the
More informationWellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer
Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer Cancer Types Rev. 10.20.15 Page 19 Breast Cancer Group Discussion True False Not Sure 1. Breast cancer is not
More informationIntroduction. Growths in the prostate can be benign (not cancer) or malignant (cancer).
This information was taken from urologyhealth.org. Feel free to explore their website to learn more. Another trusted website with good information is the national comprehensive cancer network (nccn.org).
More informationScreening for cancer in nursing home patients: Almost always a bad idea
Screening for cancer in nursing home patients: Almost always a bad idea James S. Goodwin, MD George and Cynthia Mitchell Distinguished Chair in Geriatric Medicine Director, Sealy Center on Aging August,
More informationWhat Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen).
What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen). It is a very common cancer in men; some cancers grow very slowly,
More informationApplications of Proton Therapy for Breast Cancer
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/applications-protontherapy-breast-cancer/7789/
More informationMovember and Men s Health:
Movember and Men s Health: What You Should Know! By: Jordan Rivera & Yona Lunsky With Movember here, some of you will be growing out your moustaches to raise awareness about men s health issues including
More informationQ: Why is breast cancer a big deal?
I hate breast cancer. As a radiologist who specializes in breast imaging, my career is devoted to the detection and diagnosis of breast cancer. I am passionate about women s health and my goal is to find
More informationGenetic Counselor: Hi Lisa. Hi Steve. Thanks for coming in today. The BART results came back and they are positive.
Hi, I m Kaylene Ready, a genetic counselor who specializes in the education and counseling of individuals at high-risk for hereditary breast and ovarian cancer syndrome. Women with an inherited BRCA 1
More information3/6/2018 PROSTATE CANCER IN 2018 OBJECTIVE WHAT IS THE PROSTATE? WHAT DOES IT DO? Rahul Mehan, MD
PROSTATE CANCER IN 2018 Rahul Mehan, MD East Valley Urology Center 6116 E Arbor Ave, Bldg 2, Suite 108 Mesa, AZ 85206 rmehan@evucenter.com www.evucenter.com Snapchat: Dr.NoodleKing OBJECTIVE Offer interactive
More informationThis is a summary of what we ll be talking about today.
Slide 1 Breast Cancer American Cancer Society Reviewed October 2015 Slide 2 What we ll be talking about How common is breast cancer? What is breast cancer? What causes it? What are the risk factors? Can
More informationTalking about Prostate Cancer
Talking about Prostate Cancer Talking about Prostate Cancer If I can avoid going to a doctor, I will but not when we re talking about prostate cancer. Why take chances with a condition that might be serious?
More informationChapter 6.1. pages Prayer Next Prayer Attendance Homework
Chapter 6.1 pages 108-110 Prayer Next Prayer Attendance Homework Terms Cancer A disease that begins when a single cell makes copies of itself when it should not. Cell division A process where a parent
More informationADVICE TO PATIENTS REQUESTING PSA MEASUREMENT
Frequently-Asked Questions What is the aim of this leaflet? Prostate cancer is a serious condition. The PSA test, which can give an early indication of prostate cancer, is available to you if you want
More informationQuestions and Answers about Prostate Cancer Screening with the Prostate-Specific Antigen Test
Questions and Answers about Prostate Cancer Screening with the Prostate-Specific Antigen Test About Cancer Care Ontario s recommendations for prostate-specific antigen (PSA) screening 1. What does Cancer
More informationLESSON 5.6 WORKBOOK. So what about the 'War on Cancer'?
LESSON 5.6 WORKBOOK So what about the 'War on Cancer'? This module has provided a broad perspective to cancer as a disease, switching focus among the DNA, cellular, organ, and systemic levels. As described
More informationProstate Cancer Testing. Don t be caught out
Prostate Cancer Testing Don t be caught out Prostate cancer testing What is Prostate Cancer? It is cancer of the prostate, a walnut-sized gland inside the body located in front of the urinary bladder in
More informationChapter 10-3 Regulating the Cell Cycle
Chapter 10-3 Regulating the Cell Cycle Vocabulary: Cyclin Cancer Key Concepts: How is the cell cycle regulated? How are cancer cells different from other cells? I. Introduction A. An Interesting Fact About
More informationThe prostate can be affected by three conditions that may cause problems for men as they get older.
The Prostate Gland The Prostate gland specific to males only, located in the pelvis between the bladder and rectum. It is about the shape and size of a walnut or satsuma and gets bigger as you get older.
More informationAfter Adrenal Cancer Treatment
After Adrenal Cancer Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. Lifestyle Changes After Treatment for Adrenal Cancer
More informationCell Biology and Cancer
Name: Cell Biology and Cancer Date: Questions 1. BRCA1 and BRCA2 are what types of genes? 2. List two ways that cancerous and healthy cells differ. 3. Which organelle makes proteins? 4. At what phase of
More informationSo how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent.
Welcome. My name is Amanda Brandt. I am one of the Cancer Genetic Counselors at the University of Texas MD Anderson Cancer Center. Today, we are going to be discussing how to identify patients at high
More information3:54 into mp3 file %20Dr.%20Detterbeck_254205_5_v1.mp3
Welcome to Yale Cancer Answers with your hosts doctors Anees, and Steven Gore. Dr. is Associate Professor of Surgical Oncology and Dr. Gore is Director of Hematological Malignancies at Smilow and an expert
More informationADVICE TO PATIENTS REQUESTING PSA MEASUREMENT FREQUENTLY-ASKED QUESTIONS
The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E-mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk ADVICE TO
More informationMr PHIP No. 1 Prostate cancer: Should I be tested?
Mr PHIP No. 1 cancer: Should I be tested? Having a large prostate doesn t increase your chances of having prostate cancer. No. 1 / 1 Key points cancer is the most common male cancer after skin cancer.
More informationCancer Screening: Evidence, Opinion and Fact Dialogue on Cancer April Ruth Etzioni Fred Hutchinson Cancer Research Center
Cancer Screening: Evidence, Opinion and Fact Dialogue on Cancer April 2018? Ruth Etzioni Fred Hutchinson Cancer Research Center Three thoughts to begin 1. Cancer screening is a good idea in principle Detect
More informationLESSON 4.5 WORKBOOK. How do viruses adapt Antigenic shift and drift and the flu pandemic
DEFINITIONS OF TERMS Gene a particular sequence of DNA or RNA that contains information for the synthesis of a protien or RNA molecule. For a complete list of defined terms, see the Glossary. LESSON 4.5
More informationBreast Cancer Screening
Breast Cancer Screening Claire Frost, MD R3 Talks 1 Objective 1. Understand risks and benefits of screening by reviewing current literature 2. Evaluate major society recommendations on breast cancer screening
More informationNotice that the word is pros-tate, although you will occasionally hear pros-trate! Bullet #1: other than skin cancer
Slide 1 Prostate Cancer American Cancer Society Reviewed March 2016 Slide 2 What we ll be talking about How common is prostate cancer? What is prostate cancer? What causes it? What are the risk factors?
More informationActive Surveillance for Prostate Cancer
PATIENT & CAREGIVER EDUCATION Active Surveillance for Prostate Cancer This information explains a treatment for prostate cancer called active surveillance. Not all prostate cancers are the same. Some may
More informationCell Death and Cancer. SNC 2D Ms. Papaiconomou
Cell Death and Cancer SNC 2D Ms. Papaiconomou How do cells die? Necrosis Death due to unexpected and accidental cell damage. This is an unregulated cell death. Causes: toxins, radiation, trauma, lack of
More informationAdvances and Challenges in Radiation Protection of Patients Modern Radiotherapy. Risk Acceptability
Advances and Challenges in Radiation Protection of Patients Modern Radiotherapy Risk Acceptability Versailles, France December 2-4, 2009 Fred A. Mettler Jr. M.,D., M.P.H. New Mexico Federal Regional Medical
More informationMitosis Exploration Pd. Objective: Describe the purpose and process of cellular reproduction. 1. What is a cell?
Mitosis Exploration Name Pd Objective: Describe the purpose and process of cellular reproduction. Review: 1. What is a cell? 2. Describe the main differences between a prokaryotic and eukaryotic cell.
More informationChapter 1. Dysfunctional Behavioral Cycles
Chapter 1. Dysfunctional Behavioral Cycles For most people, the things they do their behavior are predictable. We can pretty much guess what someone is going to do in a similar situation in the future
More informationPancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/pancreatic-cancerassociated-signs-symptoms-and-risk-factors-and-treatment-approaches/9552/
More informationDR. RAMESH U2 L4 MITOSIS AND CANCER
DR. RAMESH U2 L4 MITOSIS AND CANCER Objective! The student will (TSW) identify the relationship between cancer and mitosis. Benchmark/Standard LS-H-B2: Compare mitosis and meiosis Why are we learning this?!
More informationBeyond Cancer Moving On
Beyond Cancer Moving On Today, people with cancer have a better chance at living a normal life than ever before in history. In fact, there are more than 10 million survivors people who have, or are living
More informationAllinaHealthSystems 1
2018 Dimensions in Oncology Genitourinary Cancer Disclosures I have no financial or commercial relationships relevant to this presentation. Matthew O Shaughnessy, MD, PhD Director of Urologic Oncology
More informationBreast Cancer Task Force of the Greater Miami Valley A collaborative effort of health care professionals and breast cancer survivors in the Greater
Breast Cancer Task Force of the Greater Miami Valley A collaborative effort of health care professionals and breast cancer survivors in the Greater Dayton Area Last Updated Fall 2014 TABLE OF CONTENTS
More informationAfter Ovarian Cancer Treatment
After Ovarian Cancer Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. What Will Happen After Treatment for Ovarian Cancer?
More informationU.S. Preventive Services Task Force: Draft Prostate Cancer Screening Recommendation (April 2017)
1 U.S. Preventive Services Task Force: Draft Prostate Cancer Screening Recommendation (April 2017) Alex Krist MD MPH Professor and Director of Research Department of Family Medicine and Population Health
More informationWelcome! Here s our agenda for today:
Welcome! Here s our agenda for today: What is ovarian cancer? What causes it? When does genetic testing come in? When are families at risk for ovarian cancer? What are the treatments? 3 things to remember
More informationUnderstanding referrals to outpatient palliative care and goals of care discussions with individuals diagnosed with stage IV advanced cancer
Understanding referrals to outpatient palliative care and goals of care discussions with individuals diagnosed with stage IV advanced cancer ELLIS DILLON, JINNAN LI, AMY MEEHAN, SU-YING LIANG, STEVE LAI,
More informationSequencing. Deletion/Duplication Analysis. How Does Genetic Testing for Cancer Work?
There are several steps involved with genetic testing for cancer predisposition. The first step would be to meet with a specialist, such a genetic counselor, who can assess your medical and family history
More informationFrequently Asked Questions about Prostate Cancer. General questions. Patient Information. What is prostate cancer?
Patient Information English Frequently Asked Questions about Prostate Cancer The underlined terms are listed in the glossary. General questions What is prostate cancer? Prostate cancer is a malignant tumour
More informationScreening for Disease
Screening for Disease An Ounce of Prevention is Worth a Pound of Cure. Actually, an ounce of prevention is better than a pound of cure, but if prevention hasn t been effective, perhaps early identification
More informationScreening tests. When you need them and when you don t
Screening tests When you need them and when you don t S creening tests help doctors look for diseases when you don t have symptoms. The tests can Screenings find problems early, when they are easier to
More informationBreast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment?
Breast Cancer Breast Cancer Excess Estrogen Exposure Nulliparity or late pregnancy + Early menarche + Late menopause + Cystic ovarian disease + External estrogens exposure + Breast Cancer Excess Estrogen
More informationPage 3 of 8 Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate
More informationInformation leaflet for women with an increased lifetime risk of breast and ovarian cancer. Hereditary Breast and Ovarian Cancer (HBOC)
Information leaflet for women with an increased lifetime risk of breast and ovarian cancer Hereditary Breast and Ovarian Cancer (HBOC) What is Hereditary Breast and Ovarian Cancer (HBOC)? Hereditary Breast
More informationWhat do you know about your prostate? Information for Black men
What do you know about your prostate? Information for Black men Specialist Nurses 0800 074 8383 1 2 What do you know about your prostate? Did you know that in the UK, about 1 in 4 Black men will get prostate
More informationAddressing Breast Cancer's High Recurrence Rates: The Breast Cancer Translational Center of Excellence (TCE)
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/addressing-breast-cancershigh-recurrence-rates-breast-cancer-translational-center-excellence-tce/7981/
More informationFeatured Topic: Prostate Cancer (8 slides)
Featured Topic: Prostate Cancer (8 slides) Men: don t ignore a weak urine flow A weak flow of urine (or stopping and starting ) is almost always a sign of prostate problems Other symptoms: urinary urgency
More informationNational Community Health Worker Training Center (CCHD) Texas A & M School of Public Health
Breast Cancer Prevention & Detection National Community Health Worker Training Center (CCHD) Texas A & M School of Public Health Pre-test Disclaimer This study was funded by the Institute for Research
More informationPROSTATE CANCER CONTENT CREATED BY. Learn more at
PROSTATE CANCER CONTENT CREATED BY Learn more at www.health.harvard.edu TALK WITH YOUR DOCTOR Table of Contents Ask your doctor about screening and treatment options. WHAT IS PROSTATE CANCER? 4 WATCHFUL
More informationAngelina Jolie Removes Breasts to Prevent Cancer
Angelina Jolie Removes Breasts to Prevent Cancer Correction: Angelina Jolie's article in the New York Times was published on May 14, not May 21. Hi there. Thanks for joining us again on As It Is. I m Kelly
More informationsuicide Part of the Plainer Language Series
Part of the Plainer Language Series www.heretohelp.bc.ca What is? Suicide means ending your own life. It is sometimes a way for people to escape pain or suffering. When someone ends their own life, we
More informationAngelina Jolie Removes Breasts to Prevent Cancer
Angelina Jolie Removes Breasts to Prevent Cancer Hi there. Thanks for joining us again on As It Is. I m Kelly Jean Kelly. The fate of mankind will rest in the hands of one. Ooo. Don t start. Do you recognize
More informationNavigating the Stream: Prostate Cancer and Early Detection. Ifeanyi Ani, M.D. TPMG Urology Newport News
Navigating the Stream: Prostate Cancer and Early Detection Ifeanyi Ani, M.D. TPMG Urology Newport News Understand epidemiology of prostate cancer Discuss PSA screening and PSA controversy Review tools
More informationA patient s guide to understanding. Cancer. Screening
A patient s guide to understanding Cancer Screening Contents 04 06 10 12 Cancer Screening Who Should Go For Cancer Screening 05 Nasopharyngeal Carcinoma Colorectal Cancer 08 Lung Cancer Liver Cancer Breast
More informationFeatured Topic: Prostate Cancer (8 slides)
Featured Topic: Prostate Cancer (8 slides) Flawed screening for prostate cancer One million men a year undergo prostate biopsies Based on these biopsies, thousands of men will then have treatment for cancer
More informationPROSTATE CANCER SCREENING SHARED DECISION MAKING VIDEO
PROSTATE CANCER SCREENING SHARED DECISION MAKING VIDEO 1 00:00:00,067 --> 00:00:10,968 2 00:00:10,968 --> 00:00:12,701 So, you were given a decision aid sheet 3 00:00:12,701 --> 00:00:14,567 about prostate
More informationPSA To screen or not to screen? Darrel Drachenberg, MD, FRCSC
PSA To screen or not to screen? Darrel Drachenberg, MD, FRCSC Disclosures Faculty / Speaker s name: Darrel Drachenberg Relationships with commercial interests: Grants/Research Support: None Speakers Bureau/Honoraria:
More informationQuality-of-Life Effects of Prostate-Specific Antigen Screening
Quality-of-Life Effects of Prostate-Specific Antigen Screening Eveline A.M. Heijnsdijk, Ph.D., Elisabeth M. Wever, M.Sc., Anssi Auvinen, M.D., Jonas Hugosson, M.D., Stefano Ciatto, M.D., Vera Nelen, M.D.,
More informationThe Selenium and Vitamin E Prevention Trial
The largest-ever-prostate cancer prevention trial is now underway. The study will include a total of 32,400 men and is sponsored by the National Cancer Institute and a network of researchers known as the
More informationHealthy Boys POWERFUL BOYS
Healthy Boys are POWERFUL BOYS Your Sexual & Reproductive Health Education Booklet This book belongs to: Rise 2 Raise Mentoring Program By Robert Ingersoll 2 Introduction The more knowledge you have, the
More informationCancer arises from the mutation of a normal gene. A factor which brings about a mutation is called a mutagen.
Cancer Single cells divide by mitosis to form many cells. This cells undergo physical and chemical changes in order to perform specific functions. (we say the cells have Differentiated) in this way we
More informationDiagnosis and Classification of Prostate Cancer
Patient Information English 32 Diagnosis and Classification of Prostate Cancer The underlined terms are listed in the glossary. prostate biopsy is the only test that can confirm a prostate cancer diagnosis.
More informationEssential #7: Adopt Very Early Detection. Breast Cancer Conqueror 2016
Essential #7: Adopt Very Early Detection Let s face it. In America today we don t have a health care system, we have a sick care system. U.S. Senator Tom Harkins Pink Frenzy Breast Cancer Awareness Month
More informationImmunotherapy Narrative Script:
Immunotherapy Narrative Script: In order to understand immunotherapy, there are a few things we need to get straight in our heads first. The first thing we need to get a general understanding of is what
More informationTalking about Cancer in Your Family Can Keep You and Your Family Healthy. Do you know your Kin Facts? A guide for and your family
Talking about Cancer in Your Family Can Keep You and Your Family Healthy Do you know your Kin Facts? A guide for and your family Did you know? Breast and colon cancers are leading cancer killers for women
More informationCancer Screening & Prevention. Dr. Jamey Burton, MD, FAAFP
Cancer Screening & Prevention Dr. Jamey Burton, MD, FAAFP Cervical Cancer Breast Cancer Colon Cancer Prostate Cancer Lung Cancer How common is cervical cancer? What causes it? What screening is needed?
More informationThe Fallacy of Taking Random Supplements
The Fallacy of Taking Random Supplements Healthview interview with Dr. Paul Eck Healthview: We can see from our conversations that you are totally against people taking random supplements even if people
More informationCancer Screening: Controversial Topics 10/27/17. Vijay Kudithipudi, MD Kettering Cancer Care Radiation Oncology
Cancer Screening: Controversial Topics 10/27/17 Vijay Kudithipudi, MD Kettering Cancer Care Radiation Oncology Meet the Radiation Oncologists E Ronald Hale, MD, MPH Matthew Knecht, MD Anthony Paravati,
More informationX-Plain Brain Cancer Reference Summary
X-Plain Brain Cancer Reference Summary Introduction Brain tumors are not rare. About 20,000 Americans are diagnosed with brain cancer or related cancer of the nervous system. This reference summary will
More informationProstate Cancer Screening: Con. Laurence Klotz Professor of Surgery, Sunnybrook HSC University of Toronto
Prostate Cancer Screening: Con Laurence Klotz Professor of Surgery, Sunnybrook HSC University of Toronto / Why not PSA screening? Overdiagnosis Overtreatment Risk benefit ratio unfavorable Flaws of PSA
More informationX-Plain Ovarian Cancer Reference Summary
X-Plain Ovarian Cancer Reference Summary Introduction Ovarian cancer is fairly rare. Ovarian cancer usually occurs in women who are over 50 years old and it may sometimes be hereditary. This reference
More informationI MAY NOT HAVE ALL THE ANSWERS BUT AT LEAST I HAVE THE QUESTIONS TO GET THE PROPER. care guidelines
I MAY NOT HAVE ALL THE ANSWERS BUT AT LEAST I HAVE THE QUESTIONS TO GET THE PROPER care guidelines Hi, Being diagnosed with breast cancer is tough at any age, but being diagnosed when you re young makes
More informationInformation for You and Your Family
Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the
More informationEmotional Changes After a Traumatic Brain Injury
Emotional Changes After a Traumatic Brain Injury EMOTIONAL LABILITY Emotional lability can be caused by damage to the parts of the brain that control emotion. Some people with Traumatic Brain Injury or
More informationProstate cancer. A guide for men who ve just been diagnosed
Prostate cancer A guide for men who ve just been diagnosed 2 Prostate cancer A guide for men who ve just been diagnosed About this booklet This booklet is for men who ve recently been diagnosed with prostate
More informationCANCER AND THE AFRICAN WOMAN.
Africa Cancer Care Inc. CANCER AND THE AFRICAN WOMAN. Authored By Dr. Eucharia Iwuanyanwu, PA-C April 23, 2012 For a number of years now, immigrant men and women in the Houston communities have died of
More information1. Benign Prostate Hyperplexia (BPH) 2. Prostate Cancer (PCa)
Objectives: Our first segment focused in the anatomy and functions of the prostate gland, to get a clear understanding of the male Genito-Urinary System. Now, we will explore two of the main problems associated
More informationHenda s Law. Supplemental screening for women with dense breast tissue and increased risk
. Henda s Law Supplemental screening for women with dense breast tissue and increased risk The 2011 Texas Legislature passed House Bill 2102 which is effective 1st September 2011. The law is informally
More information